FDA-cleared profile

Vivid iq

GE Medical Systems Ultrasound and Primary Care Diagnostics · Ultrasound · FDA-cleared (510(k))

Authorized purpose: Vivid iq is a compact Track 3 general-purpose diagnostic ultrasound system for trained healthcare professionals, with labeled cardiac, vascular, abdominal, obstetric, small-organ, musculoskeletal, urologic, transcranial, transrectal, transvaginal, transesophageal, interventional, thoracic, and intraoperative applications.

Clinical role
Acquires and displays ultrasound data and supports labeled cardiac, vascular, shared-service, interventional, and other clinical applications with measurement and review.
Images and patients
Ultrasound · Multi-region; cardiovascular and shared-service ultrasound applications
Key limitation
Keep in mind: Use depends on the labeled application, probe, patient population, operator training, image quality, and configured system options; remote viewing is not itself diagnostic and clinicians retain interpretation responsibility.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Vivid iq is a compact Track 3 general-purpose diagnostic ultrasound system for trained healthcare professionals, with labeled cardiac, vascular, abdominal, obstetric, small-organ, musculoskeletal, urologic, transcranial, transrectal, transvaginal, transesophageal, interventional, thoracic, and intraoperative applications.
  • Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Multi-region; cardiovascular and shared-service ultrasound applications Input: Real-time ultrasound signals from compatible transthoracic, transesophageal, vascular, and procedural probes plus optional ECG.
  • Who uses it?Intended users: Trained physicians, sonographers, and other qualified healthcare professionals operating the supported ultrasound system and probes.
  • What does the software produce?Output: Diagnostic ultrasound images, measurements, DICOM-encapsulated PDF, remote-viewing or workflow displays, and supported cardiac, vascular, and shared-service outputs.
  • What is its most important limitation?Key limitation: Use depends on the labeled application, probe, patient population, operator training, image quality, and configured system options; remote viewing is not itself diagnostic and clinicians retain interpretation responsibility.

Clinical takeaway. Clinical role: Vivid iq is a compact Track 3 general-purpose diagnostic ultrasound system for trained healthcare professionals, with labeled cardiac, vascular, abdominal, obstetric, small-organ, musculoskeletal, urologic, transcranial, transrectal, transvaginal, transesophageal, interventional, thoracic, and intraoperative applications.

Evidence takeaway. Evidence from the reviewed source record: The exact FDA material supports the broad labeled Vivid iq ultrasound scope; preserved exact-product evidence records a Sleep Mode daily power-reduction metric and selected software or interoperability functions without generalizing them to other configurations.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Vivid iq is a compact Track 3 general-purpose diagnostic ultrasound system for trained healthcare professionals, with labeled cardiac, vascular, abdominal, obstetric, small-organ, musculoskeletal, urologic, transcranial, transrectal, transvaginal, transesophageal, interventional, thoracic, and intraoperative applications.
  • Exact FDA submission
  • Checked 2026-09-04
Workflow role
Acquires and displays ultrasound data and supports labeled cardiac, vascular, shared-service, interventional, and other clinical applications with measurement and review.
  • Exact FDA submission
  • Checked 2026-09-04

Prior source-backed dossier value: Portable cardiovascular and general ultrasound acquisition, measurement, analysis, procedural support, and report exchange.

Required input
Real-time ultrasound signals from compatible transthoracic, transesophageal, vascular, and procedural probes plus optional ECG.
  • Exact FDA submission
  • Checked 2026-09-04
Output and clinician action
Diagnostic ultrasound images, measurements, DICOM-encapsulated PDF, remote-viewing or workflow displays, and supported cardiac, vascular, and shared-service outputs.
  • Exact FDA submission
  • Checked 2026-09-04

Prior source-backed dossier value: Ultrasound images, Doppler information, measurements, analysis, clips, and configured reports.

Care setting
Hospitals, echocardiography laboratories, operating rooms, catheterization or electrophysiology laboratories, private offices, and other labeled ultrasound settings.
  • Exact FDA submission
  • Checked 2026-09-04

Prior source-backed dossier value: Hospitals, operating rooms, catheterization or electrophysiology labs, private offices, and limited labeled settings outside healthcare facilities.

Intended users
Trained physicians, sonographers, and other qualified healthcare professionals operating the supported ultrasound system and probes.
  • Exact FDA submission
  • Checked 2026-09-04

Prior source-backed dossier value: Qualified physicians, sonographers, and other trained diagnostic or interventional ultrasound professionals.

Limitations
Use depends on the labeled application, probe, patient population, operator training, image quality, and configured system options; remote viewing is not itself diagnostic and clinicians retain interpretation responsibility.
  • Exact FDA submission
  • Checked 2026-09-04

Prior source-backed dossier value: Remote viewing is not for diagnosis. Vascular-access, catheter, probe, AI, and analysis support differ by configuration, and Sleep Mode’s energy result is not a clinical performance endpoint.

Evidence summary
The exact FDA material supports the broad labeled Vivid iq ultrasound scope; preserved exact-product evidence records a Sleep Mode daily power-reduction metric and selected software or interoperability functions without generalizing them to other configurations.
  • Exact FDA submission
  • Checked 2026-09-04

Prior source-backed dossier value: K243620 describes manufacturer system, probe, image-quality, software, DICOM, Sleep Mode, and application testing. Current vendor workflow claims are product-family supplied and require local verification.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
The exact FDA material supports the broad labeled Vivid iq ultrasound scope; preserved exact-product evidence records a Sleep Mode daily power-reduction metric and selected software or interoperability functions without generalizing them to other configurations.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04

Prior source-backed dossier value: K243620 describes manufacturer system, probe, image-quality, software, DICOM, Sleep Mode, and application testing. Current vendor workflow claims are product-family supplied and require local verification.

Reported sensitivity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-04

Sensitivity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or dose-delivery function. Use the task-specific endpoints and tested population reported below. Sensitivity is not promoted as a product-wide endpoint. Compare only an exact endpoint, threshold, population, version, and source if later verified.

Reported specificity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-04

Specificity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or dose-delivery function. Use the task-specific endpoints and tested population reported below. Specificity is not promoted as a product-wide endpoint. Compare only an exact endpoint, threshold, population, version, and source if later verified.

Sleep Mode daily power reduction

22 %

  • EndpointDaily power consumption reduction described for the cleared Sleep Mode
  • PopulationVivid iq
  • Tested versionVivid iq release cleared in K243620

K243620 FDA performance package for Vivid iq

  • DesignManufacturer ultrasound-system, probe, acoustic-output, image-quality, software, energy-use, interoperability, and usability verification
  • PopulationRepresentative cardiovascular, vascular-access, thoracic, intraoperative, and interventional ultrasound workflows
  • Scopeexact submission
  • Tested versionVivid iq release cleared in K243620
  • IndependenceSponsor or vendor study

K243620

Manufacturer evidence submitted for substantial equivalence; local clinical, technical, and workflow acceptance remains necessary.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The 2026-09-02 openFDA device-recall snapshot contained no record matched to K243620 by exact native submission identifier. This does not exclude product-family, later-version, or adverse-event information.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-04

Exact-identifier review does not prove absence of all product-family safety signals. Prior source-backed dossier value: The 2026-09-02 openFDA device-recall snapshot contained no record matched to K243620 by exact submission identifier.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.

Reimbursement

Reimbursement
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the product within the applicable imaging or clinical service line and verify payer, site-of-service, coding, and coverage assumptions independently.
  • Service-level, not product-specific
  • Checked 2026-09-04

Prior source-backed dossier value: No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the device within the applicable imaging or surgical service line and verify payer, site-of-service, and coding assumptions independently.

No product-specific code

No separate named-product payment identified in reviewed public material

Centers for Medicare & Medicaid Services · United States

Build a local total-cost and value model; do not infer reimbursement from FDA clearance.

No product-specific code

No separate named-product payment identified in reviewed public material

Centers for Medicare & Medicaid Services · United States

This is not a product-specific reimbursement determination. Verify payer, site-of-service, coding, and coverage assumptions independently.

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Real-time ultrasound signals from compatible transthoracic, transesophageal, vascular, and procedural probes plus optional ECG.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-04 · FDA 510(k) decision material K243620: Vivid iq

  2. Routing

    Source context, not route validation: The FDA and preserved exact-product evidence describe supported probes and catheters, DICOM-encapsulated PDF, remote viewing, Carto 3, Vascular Access, and the system's clinical applications.

    Scope: Exact FDA submission. This is the interface boundary described in the exact FDA decision material; current local compatibility, routing, identity, archive, and downtime behavior still require acceptance testing. Prior source-backed dossier value: DICOM networking with encapsulated PDF support in the cleared release; validate measurement, structured-report, clip, worklist, and PACS behavior.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-04 · FDA 510(k) decision material K243620: Vivid iq · Vivid iq cardiovascular ultrasound system

  3. AI processing

    Source context, not route validation: The FDA material describes a compact mobile-cart ultrasound console; current room, network, archive, service, security, and enabled-option configuration remain unverified.

    Scope: Exact FDA submission. This is the release-level boundary described in the exact FDA decision material; current hosting, contracts, security, availability, upgrade path, and site configuration remain separate evidence. Prior source-backed dossier value: Portable cardiovascular ultrasound console with model-specific probes, battery, software, networking, and service options.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-04 · FDA 510(k) decision material K243620: Vivid iq · Vivid iq cardiovascular ultrasound system

  4. Returned objects

    Source context, not route validation: Diagnostic ultrasound images, measurements, DICOM-encapsulated PDF, remote-viewing or workflow displays, and supported cardiac, vascular, and shared-service outputs.

    Scope: Exact FDA submission. Prior source-backed dossier value: Ultrasound images, Doppler information, measurements, analysis, clips, and configured reports.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-04 · FDA 510(k) decision material K243620: Vivid iq

  5. Viewer/worklist/report

    Unresolved route: Diagnostic ultrasound images, measurements, DICOM-encapsulated PDF, remote-viewing or workflow displays, and supported cardiac, vascular, and shared-service outputs.

    Scope: Exact FDA submission. Prior source-backed dossier value: Ultrasound images, Doppler information, measurements, analysis, clips, and configured reports.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-04 · FDA 510(k) decision material K243620: Vivid iq

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The FDA material describes a compact mobile-cart ultrasound console; current room, network, archive, service, security, and enabled-option configuration remain unverified.
  • Exact FDA submission
  • Checked 2026-09-04

This is the release-level boundary described in the exact FDA decision material; current hosting, contracts, security, availability, upgrade path, and site configuration remain separate evidence. Prior source-backed dossier value: Portable cardiovascular ultrasound console with model-specific probes, battery, software, networking, and service options.

Integration
The FDA and preserved exact-product evidence describe supported probes and catheters, DICOM-encapsulated PDF, remote viewing, Carto 3, Vascular Access, and the system's clinical applications.
  • Exact FDA submission
  • Checked 2026-09-04

This is the interface boundary described in the exact FDA decision material; current local compatibility, routing, identity, archive, and downtime behavior still require acceptance testing. Prior source-backed dossier value: DICOM networking with encapsulated PDF support in the cleared release; validate measurement, structured-report, clip, worklist, and PACS behavior.

Security
GE HealthCare's Product Security Portal is described as a credentialed global portal giving customers security updates, vulnerability status and required actions for GE HealthCare products potentially impacted by critical vulnerabilities, plus historical patch views; GE HealthCare references its Cybersecurity Risk Management System and publishes a Coordinated Vulnerability Disclosure Statement for reporting vulnerabilities in GE HealthCare products.
  • Vendor-wide
  • Checked 2026-10-26

Vendor statement, not an attestation. Identity bridge: GE HealthCare's own Privacy Shield page on gehealthcare.com names GE Medical Systems, Ultrasound & Primary Care Diagnostics LLC as a US entity of the GEHC group. Corporate program statement; portal content is credentialed; exact-release scope is not established.

Training
Only Trained physicians, sonographers, and other qualified healthcare professionals operating the supported ultrasound system and probes should operate or interpret the product; local onboarding must cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
  • Exact FDA submission
  • Checked 2026-09-04

Prior source-backed dossier value: Only qualified physicians, sonographers, and other trained diagnostic or interventional ultrasound professionals. should operate or interpret the system. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.

Monitoring
Monitor K243620 by exact hardware, software, model, algorithm version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track these product-specific limits: Use depends on the labeled application, probe, patient population, operator training, image quality, and configured system options; remote viewing is not itself diagnostic and clinicians retain interpretation responsibility.
  • Exact FDA submission
  • Checked 2026-09-04

Buyer-facing monitoring guidance derived from the exact cleared scope; it is not a claim that the FDA package provides a live monitoring service. Prior source-backed dossier value: Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: Remote viewing is not for diagnosis. Vascular-access, catheter, probe, AI, and analysis support differ by configuration, and Sleep Mode’s energy result is not a clinical performance endpoint.

Release and scope verification

Map the installed model, build, options, population, anatomy, inputs, and outputs to K243620 before acceptance.

exact submission · checked 2026-09-03

Later product-family features are not evidence that this cleared release includes them.

Interoperability acceptance

DICOM networking with encapsulated PDF support in the cleared release; validate measurement, structured-report, clip, worklist, and PACS behavior.

exact submission · checked 2026-09-03

Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.

Clinical acceptance

Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Remote viewing is not for diagnosis. Vascular-access, catheter, probe, AI, and analysis support differ by configuration, and Sleep Mode’s energy result is not a clinical performance endpoint.

exact submission · checked 2026-09-03

Define stop-use, escalation, rollback, and revalidation triggers before production use.

Economic evaluation

Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.

product family · checked 2026-09-03

Vendor productivity claims are scenario inputs, not guaranteed local savings.

Lifecycle monitoring

Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: Remote viewing is not for diagnosis. Vascular-access, catheter, probe, AI, and analysis support differ by configuration, and Sleep Mode’s energy result is not a clinical performance endpoint.

exact submission · checked 2026-09-03

Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.

Deployment boundary

The FDA material describes a compact mobile-cart ultrasound console; current room, network, archive, service, security, and enabled-option configuration remain unverified.

exact submission · checked 2026-09-04

FDA-described deployment boundaries do not establish current hosting contracts, security controls, uptime, or local qualification.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K243620
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Ultrasound
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04
Anatomy
Multi-region; cardiovascular and shared-service ultrasound applications
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04

Prior source-backed dossier value: Heart/Cardiovascular

Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2025-02-11
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-04Last searched
32Fields reviewed
11Source classes checked
2Screened PubMed leads
10Screened trial leads
0Unreviewed FDA recall leads

Screened two PubMed and 10 ClinicalTrials.gov records. Some records use or mention Vivid iq hardware, but none identifies the tested release and enabled options as the exact K243620 configuration; all 12 were quarantined and none was promoted. The current discovery snapshot contains 2 PubMed and 10 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, fda decision material, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, vendor product page, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not publicly available - checked 2026-09-04 - Exact FDA submission

    No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, enabled features, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs. Obtain a written quote separating hardware or license basis, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed

8 sources - 3 history items

Source ledger

  1. FDA 510(k) decision material K243620: Vivid iq

    U.S. Food and Drug Administration - Published 2025-02-11 - Accessed 2026-09-04

    Scope: identity, productIdentity, purpose, clinicalUse, modality, anatomy, intendedUsers, careSetting, workflowRole, input, output, limitations, evidenceSummary

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  4. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  5. Medicare Coverage Database

    Centers for Medicare & Medicaid Services - Accessed 2026-09-01

    Scope: coverage, codingContext

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. Vivid iq cardiovascular ultrasound system

    GE HealthCare - Accessed 2026-09-03

    Scope: productFamily, workflowRole, implementationCapabilities, currentCommercialContext

  8. GE HealthCare: Product Security (portal and Cybersecurity Risk Management System)

    GE HealthCare - Accessed 2026-10-26

    Scope: security

Research history

  1. K243620 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K260667

Alturion Series Diagnostic Ultrasound System

Philips Ultrasound, LLC

Authorized purpose: Alturion Series diagnostic ultrasound systems acquire and display ultrasound images and fluid-flow information for the labeled fetal, abdominal, cardiac, cephalic, obstetric, musculoskeletal, ophthalmic, urologic, vascular, small-organ, and lung examinations.

Modality
Ultrasound
Anatomy
Fetus; abdomen; pelvis; small organs; head; heart; peripheral vessels; musculoskeletal anatomy; ophthalmic; urologic organs; and lung
Decision
2026-06-29
FDA-cleared K260844

ACUSON Sequoia Diagnostic Ultrasound System;ACUSON Sequoia Select Diagnostic Ultrasound System;ACUSON Origin Diagnostic Ultrasound System;ACUSON Origin ICE Diagnostic Ultrasound System

Siemens Medical Solutions USA, Inc.

Authorized purpose: ACUSON Sequoia, Select, Origin, and Origin ICE diagnostic ultrasound systems acquire and display the labeled fetal, abdominal, pediatric, neonatal, cephalic, small-part, obstetric, cardiac, transesophageal, intracardiac, vascular, and musculoskeletal examinations.

Modality
Ultrasound
Anatomy
Fetus; abdomen; pelvis; small organs; head; heart; peripheral vessels; musculoskeletal anatomy; transesophageal and intracardiac applications
Decision
2026-06-16
FDA-cleared K260300

WatchMate Software

Anumana, Inc.

Authorized purpose: WatchMate Software v1.2.0 processes transesophageal echocardiography data to reconstruct the left atrial appendage and assist preprocedural planning and device sizing during left-atrial-appendage closure.

Modality
Ultrasound
Anatomy
Heart and left atrial appendage
Decision
2026-06-15
FDA-cleared K260780

HeartFocus

Deski

Authorized purpose: Guides medical professionals acquiring ten standard 2D transthoracic echocardiographic views in adults requiring a cardiac ultrasound examination; acquired images require qualified clinical interpretation.

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2026-06-03

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history